Avantor, Inc. (NYSE:AVTR) Stock Holdings Lessened by Tidal Investments LLC

Tidal Investments LLC lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 17.2% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,821 shares of the company’s stock after selling 2,449 shares during the period. Tidal Investments LLC’s holdings in Avantor were worth $306,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp increased its stake in shares of Avantor by 1.6% in the second quarter. Bank of New York Mellon Corp now owns 2,325,329 shares of the company’s stock valued at $49,297,000 after purchasing an additional 35,497 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Avantor by 35.1% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,157,855 shares of the company’s stock valued at $24,547,000 after acquiring an additional 300,579 shares in the last quarter. Cambridge Investment Research Advisors Inc. acquired a new position in shares of Avantor in the 2nd quarter valued at about $2,353,000. Kintegral Advisory LLC purchased a new stake in shares of Avantor in the second quarter worth approximately $514,000. Finally, Whittier Trust Co. boosted its holdings in shares of Avantor by 5.0% during the second quarter. Whittier Trust Co. now owns 199,715 shares of the company’s stock worth $4,234,000 after purchasing an additional 9,449 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 0.5 %

NYSE:AVTR opened at $21.36 on Wednesday. The company’s 50 day moving average is $22.07 and its 200-day moving average is $23.42. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The firm has a market cap of $14.54 billion, a price-to-earnings ratio of 46.43, a P/E/G ratio of 2.75 and a beta of 1.29.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on AVTR shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Wells Fargo & Company lowered their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. UBS Group cut their price target on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, October 8th. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Avantor currently has an average rating of “Moderate Buy” and an average target price of $27.69.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.